| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |